–
July 29, 2021
29 July 2021
12:30 – 1:30 pm PDT | 3:30 – 4:30 pm EDT
Four presentations:
Design and in-vivo evaluation of lipid nanoparticles with a triple adjuvant to achieve enhanced immunity against Bordetella pertussis
Noorjahan Aibani
University of Saskatchewan
A platform for automated functionalization of lipid nanoparticles for CAR T cell therapy
Quinn Matthews
University of Toronto
Development of In-Situ Non-Viral Gene Editing Strategies for Monogenic Skin Disease (ARCI)
Qurrat Ul Ain
University of British Columbia
Dose-dependencies in the plasma pharmacokinetics of a long-circulating porphyrin-lipid based nanoparticle
Michael Valic
University of Toronto